Cancer risk assessment for the inhalation of 1,3-butadiene using physiologically based pharmacokinetic modeling

Bulletin of Environmental Contamination and Toxicology ◽

10.1007/bf00193342 ◽

1992 ◽

Vol 49 (1) ◽

Author(s):

WilliamH. Hallenbeck

Keyword(s):

Risk Assessment ◽

Cancer Risk ◽

Pharmacokinetic Modeling ◽

Cancer Risk Assessment ◽

Physiologically Based Pharmacokinetic Modeling ◽

Physiologically Based Pharmacokinetic ◽

Physiologically Based

Download Full-text

Tissue dosimetry, physiologically-based pharmacokinetic modeling, and cancer risk assessment

Cell Biology and Toxicology ◽

10.1007/bf00118411 ◽

1989 ◽

Vol 5 (4) ◽

pp. 405-415 ◽

Author(s):

Melvin E. Andersen

Keyword(s):

Risk Assessment ◽

Cancer Risk ◽

Pharmacokinetic Modeling ◽

Cancer Risk Assessment ◽

Physiologically Based Pharmacokinetic Modeling ◽

Physiologically Based Pharmacokinetic ◽

Physiologically Based

Download Full-text

Risk Assessment of Predicted Serum Concentrations of Bisphenol A in Children and Adults Following Treatment with Dental Composite Restoratives, Dental Sealants, or Orthodontic Adhesives using Physiologically Based Pharmacokinetic Modeling

Regulatory Toxicology and Pharmacology ◽

10.1016/j.yrtph.2020.104839 ◽

2020 ◽

pp. 104839

Author(s):

Bradford D. Bagley ◽

Jordan N. Smith ◽

Justin G. Teeguarden

Keyword(s):

Risk Assessment ◽

Bisphenol A ◽

Pharmacokinetic Modeling ◽

Dental Composite ◽

Serum Concentrations ◽

Physiologically Based Pharmacokinetic Modeling ◽

Orthodontic Adhesives ◽

Physiologically Based Pharmacokinetic ◽

Dental Sealants ◽

Physiologically Based

Download Full-text

081030 (M10, B20) A tricholoethylene risk assessment using a Monte Carlo analysis of parameter uncertainty in conjunction with physiologically-based pharmacokinetic modeling

Insurance Mathematics and Economics ◽

10.1016/0167-6687(96)81409-0 ◽

1996 ◽

Vol 18 (2) ◽

pp. 140

Keyword(s):

Risk Assessment ◽

Monte Carlo ◽

Parameter Uncertainty ◽

Monte Carlo Analysis ◽

Pharmacokinetic Modeling ◽

Physiologically Based Pharmacokinetic Modeling ◽

Physiologically Based Pharmacokinetic ◽

Physiologically Based

Download Full-text

Examples of physiologically based pharmacokinetic modeling applied to risk assessment

Physiologically Based Pharmacokinetic (PBPK) Modeling ◽

10.1016/b978-0-12-818596-4.00011-4 ◽

2020 ◽

pp. 281-299

Author(s):

Lisa M. Sweeney ◽

Jeffery M. Gearhart

Keyword(s):

Risk Assessment ◽

Pharmacokinetic Modeling ◽

Physiologically Based Pharmacokinetic Modeling ◽

Physiologically Based Pharmacokinetic ◽

Physiologically Based

Download Full-text

Physiologically-Based Pharmacokinetic and Toxicokinetic Models in Cancer Risk Assessment

Journal of Environmental Science and Health Part C ◽

10.1081/gnc-200051856 ◽

2005 ◽

Vol 23 (1) ◽

pp. 31-53 ◽

Author(s):

Kannan Krishnan<sup>1</sup>,<sup>2</sup> ◽

Gunnar Johanson<sup>2</sup>

Keyword(s):

Risk Assessment ◽

Cancer Risk ◽

Cancer Risk Assessment ◽

Physiologically Based Pharmacokinetic ◽

Physiologically Based

Download Full-text

Incorporation of in vitro metabolism data and physiologically based pharmacokinetic modeling in a risk assessment for chloroprene

Inhalation Toxicology ◽

10.1080/08958378.2020.1715513 ◽

2019 ◽

Vol 31 (13-14) ◽

pp. 468-483 ◽

Author(s):

Harvey J. Clewell ◽

Jerry L. Campbell ◽

Cynthia Van Landingham ◽

Allison Franzen ◽

Miyoung Yoon ◽

...

Keyword(s):

Risk Assessment ◽

Pharmacokinetic Modeling ◽

In Vitro Metabolism ◽

Physiologically Based Pharmacokinetic Modeling ◽

Physiologically Based Pharmacokinetic ◽

Physiologically Based

Download Full-text

Response to “letter concerning: Clewell (2019) incorporation of in vitro metabolism data and physiologically based pharmacokinetic modeling in a risk assessment for chloroprene.” (UIHT-2020-0053)

Inhalation Toxicology ◽

10.1080/08958378.2020.1817199 ◽

2020 ◽

Vol 32 (9-10) ◽

pp. 369-371

Author(s):

H. J. Clewell ◽

J. L. Campbell ◽

C. Van Landingham ◽

A. Franzen ◽

M. Yoon ◽

...

Keyword(s):

Risk Assessment ◽

Pharmacokinetic Modeling ◽

In Vitro Metabolism ◽

Physiologically Based Pharmacokinetic Modeling ◽

Physiologically Based Pharmacokinetic ◽

Physiologically Based

Download Full-text

Cancer risk assessment for dioxane based upon a physiologically-based pharmacokinetic approach

Toxicology Letters ◽

10.1016/0378-4274(90)90207-3 ◽

1990 ◽

Vol 51 (2) ◽

pp. 147-162 ◽

Author(s):

Leung Hon-Wing ◽

Dennis J. Paustenbach

Keyword(s):

Risk Assessment ◽

Cancer Risk ◽

Cancer Risk Assessment ◽

Physiologically Based Pharmacokinetic ◽

Physiologically Based ◽

Pharmacokinetic Approach

Download Full-text

A computer program linking physiologically based pharmacokinetic model with cancer risk assessment for breast-fed infants

Computer Methods and Programs in Biomedicine ◽

10.1016/0169-2607(94)01616-n ◽

1995 ◽

Vol 46 (2) ◽

pp. 155-163 ◽

Author(s):

Janusz Z. Byczkowski ◽

Jeffrey W. Fisher

Keyword(s):

Risk Assessment ◽

Cancer Risk ◽

Computer Program ◽

Pharmacokinetic Model ◽

Cancer Risk Assessment ◽

Physiologically Based Pharmacokinetic Model ◽

Physiologically Based Pharmacokinetic ◽

Physiologically Based ◽

Download Full-text

Application of Physiologically Based Pharmacokinetic Modeling in Health Risk Assessment

Quantitative Modeling in Toxicology ◽

10.1002/9780470686263.ch19 ◽

2010 ◽

pp. 399-428

Author(s):

Harvey J. Clewell

Keyword(s):

Risk Assessment ◽

Health Risk ◽

Health Risk Assessment ◽

Pharmacokinetic Modeling ◽

Physiologically Based Pharmacokinetic Modeling ◽

Physiologically Based Pharmacokinetic ◽

Physiologically Based

Download Full-text